Related Experiment Videos
Gastrointestinal leiomyoma and leiomyosarcoma: CT differentiation
1Department of Radiology, Catholic University Medical College, Kangnam St. Mary's Hospital, Seoul, Korea.
Journal of Computer Assisted Tomography
|February 4, 1998
Summary
Computed tomography (CT) effectively distinguishes gastrointestinal leiomyomas from leiomyosarcomas. Key CT indicators of malignancy include size, contour, enhancement, and invasion, aiding in diagnosis.
Area of Science:
- Gastrointestinal Radiology
- Oncologic Imaging
- Surgical Pathology
Background:
- Gastrointestinal leiomyomas and leiomyosarcomas are mesenchymal tumors with overlapping imaging features.
- Accurate differentiation is crucial for appropriate patient management and treatment planning.
Purpose of the Study:
- To evaluate the efficacy of computed tomography (CT) in differentiating gastrointestinal leiomyoma from leiomyosarcoma.
- To identify specific CT features indicative of malignancy.
Main Methods:
- Retrospective review of CT scans from 45 patients with surgically confirmed gastrointestinal leiomyomas (n=21) and leiomyosarcomas (n=24).
- Analysis of CT features including size, contour, enhancement, fat infiltration, calcification, ulceration, lymphadenopathy, invasion, metastasis, and growth pattern.
- Subjective diagnostic categorization into probable benign, probable malignant, and diagnostic malignant groups.
Main Results:
- Significant CT features favoring malignancy included larger size (>5 cm), lobulated contour, heterogeneous enhancement, mesenteric fat infiltration, ulceration, regional lymphadenopathy, and exophytic growth (p < 0.005).
- Direct invasion and distant metastasis were also indicative of malignancy.
- Calcification was not a significant differentiating factor (p = 0.25163).
- Subjective analysis achieved 89% sensitivity, 85% specificity, and 87% accuracy for leiomyosarcoma diagnosis.
Conclusions:
- CT imaging possesses significant utility in differentiating gastrointestinal leiomyoma from leiomyosarcoma.
- Specific CT findings can reliably predict malignancy, guiding clinical decision-making.